Tenofovir disoproxil

A summary of the most common chemical descriptors (InChI Key and SMILES codes) for Tenofovir disoproxil are summarized together with 3D and 2D structures and relevant physico-chemical properties.

What is the Tenofovir disoproxil?

The molecule Tenofovir disoproxil presents a molecular formula of C19H30N5O10P and its IUPAC name is [[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate.

Tenofovir disoproxil is a nucleotide reverse transcriptase inhibitor (NRTI) used as an antiretroviral medication for the treatment of HIV/AIDS and hepatitis B. It is generally well tolerated. The most common side effects are gastrointestinal and include diarrhea, nausea, and flatulence. Less common side effects include headache, dizziness, and depression..

Tenofovir disoproxil was first approved by the US Food and Drug Administration (FDA) in 2001. It exists in generic form and under the brand names Viread and Truvada. It is also available in a fixed-dose combination with emtricitabine as Atripla..

Tenofovir disoproxil is a prodrug of tenofovir, which is metabolized in the body to the active form, tenofovir diphosphate. Tenofovir diphosphate inhibits the activity of HIV-1 reverse transcriptase, which is required for the replication of HIV-1..

Tenofovir disoproxil is effective against HIV-1 strains that are resistant to other NRTIs. It is also active against hepatitis B virus (HBV)..

Tenofovir disoproxil is generally well tolerated. The most common side effects are gastrointestinal and include diarrhea, nausea, and flatulence. Less common side effects include headache, dizziness, and depression..

Tenofovir disoproxil can cause kidney damage. There have also been reports of bone loss and osteoporosis with long-term use of tenofovir disoproxil..

Pregnant women should not take tenofovir disoproxil because it can cause birth defects. Women of childbearing potential should use effective birth control while taking tenofovir disoproxil..

Tenofovir disoproxil is a nucleotide reverse transcriptase inhibitor (NRTI) used as an antiretroviral medication for the treatment of HIV/AIDS and hepatitis B. It is generally well tolerated. The most common side effects are gastrointestinal and include diarrhea, nausea, and flatulence. Less common side effects include headache, dizziness, and depression..

Tenofovir disoproxil was first approved by the US Food and Drug Administration (FDA) in 2001. It exists in generic form and under the brand names Viread and Truvada. It is also available in a fixed-dose combination with emtricitabine as Atripla..

Tenofovir disoproxil is a prodrug of tenofovir, which is metabolized in the body to the active form, tenofovir diphosphate. Tenofovir diphosphate inhibits the activity of HIV-1 reverse transcriptase, which is required for the replication of HIV-1..

Tenofovir disoproxil is effective against HIV-1 strains that are resistant to other NRTIs. It is also active against hepatitis B virus (HBV)..

Tenofovir disoproxil is generally well tolerated. The most common side effects are gastrointestinal and include diarrhea, nausea, and flatulence. Less common side effects include headache, dizziness, and depression..

Tenofovir disoproxil can cause kidney damage. There have also been reports of bone loss and osteoporosis with long-term use of tenofovir disoproxil..

Pregnant women should not take tenofovir disoproxil because it can cause birth defects. Women of childbearing potential should use effective birth control while taking tenofovir disoproxil..

3D structure

Cartesian coordinates

Geometry of Tenofovir disoproxil in x, y and z coordinates (Å units) to copy/paste elsewhere. Generated with Open Babel software.

2D drawing

 

Tenofovir disoproxil JFVZFKDSXNQEJW-CQSZACIVSA-N chemical compound 2D structure molecule svg
Tenofovir disoproxil

 

Molecule descriptors

 
IUPAC name[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate
InChI codeInChI=1S/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1
InChI KeyJFVZFKDSXNQEJW-CQSZACIVSA-N
SMILESCC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc21)OCOC(=O)OC(C)C

Other names (synonyms)

IUPAC nomenclature provides a standardized method for naming chemical compounds. Although this system is widely used in chemistry, many chemical compounds have also other names commonly used in different contexts. These synonyms can come from a variety of sources and are used for a variety of purposes.

One common source of synonyms for chemical compounds is the common or trivial names, assigned on the basis of appearance, properties, or origin of the molecule.

Another source of synonyms are historical or obsolete names employed in the past, however replaced nowadays by more modern or standardized names.

In addition to common and historical names, chemical compounds may also have synonyms that are specific to a particular field or industry.

  • (R)-(((((1-(6-Amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene)diisopropyldicarbonate
  • (R)-(((((1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphoryl)bis(oxy))bis(methylene) diisopropyl bis(carbonate)
  • (R)-(((1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methyl)phosphoryl)bis(oxy)bis(methylene) isopropyl dicarbonate
  • (r)-bis(poc)pmpa
  • 138T509
  • 2,4,6,8-TETRAOXA-5-PHOSPHANONANEDIOIC ACID, 5-(((1R)-2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY)METHYL)-, 1,9-BIS(1-METHYLETHYL) ESTER, 5-OXIDE
  • 2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide
  • 201341-05-1
  • 202138-50-9
  • 9-((R)-2-((Bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine
  • A814272
  • AB01568241_01
  • AMY11134
  • BDBM77145
  • Bis(POC)-PMPA;GS 4331
  • Bis(POC)PMPA
  • Bis(isopropyloxymethylcarbonyl)PMPA
  • CS-5922
  • DB00300
  • F4YU4LON7I
  • GS 4331-05 (*1:1 Fumarate salt*)
  • GS-4331
  • HY-13782A
  • J-519478
  • MFCD00952920
  • MLS006010919
  • NCGC00183876-02
  • PMPA prodrug
  • Q27132753
  • SMR004701787
  • STRIBILD COMPONENT TENOFOVIR DISOPROXIL
  • TELURA COMPONENT OF TENOFOVIR DISOPROXIL
  • TENOFOVIR DISOPROXIL (GS 4331)
  • Tenofovir (Disoproxil)
  • Tenofovir Disoproxil Fumarate
  • Tenofovir disoproxil
  • Tenofovirdisoproxil
  • Viread(TM) (*1:1 Fumarate salt*)
  • [[(1R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methyl-(isopropoxycarbonyloxymethoxy)phosphoryl]oxymethyl isopropyl carbonate
  • [[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate
  • bis({[(propan-2-yloxy)carbonyl]oxy}methyl) ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonate
  • bis-POC-PMPA
  • s5959
  • tenofovir bis(isopropyloxycarbonyloxymethyl) ester
  • tenofovir-disoproxil

Reference codes for other databases

There exist several different chemical codes commonly used in orded to identify molecules:
  • ZINC3929022
  • UNII-F4YU4LON7I
  • AKOS015895093
  • DTXSID5052757
  • CHEMBL1538
  • CHEBI:63717
  • SCHEMBL52793

Physico-Chemical properties

IUPAC name[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate
Molecular formulaC19H30N5O10P
Molecular weight519.443
Melting point (ºC)
Boiling point (ºC)
Density (g/cm3)
Molar refractivity120.92
LogP3.6
Topological polar surface area195.3

LogP and topological polar surface area (TPSA) values were estimated using Open Babel software.

The n-octanol/water partition coeficient (Kow) data is applied in toxicology and drug research. Kow values are used, to guess the environmental fate of persistent organic pollutants. High partition coefficients values, tend to accumulate in the fatty tissue of organisms. Molecules with a log(Kow) (or LogP) greater than 5 are considered to bioaccumulate.

TPSA values are the sum of the surface area over all polar atoms or molecules, mainly oxygen and nitrogen, also including hydrogen atoms.

In medicinal chemistry, TPSA is used to assess the ability of a drug to permeabilise cells.

For molecules to penetrate the blood-brain barrier (and act on receptors in the central nervous system), TPSA values below 90 Å2 are required. Thus, molecules with a polar surface area greater than 140 Å2 tend to be poorly permeable to cell membranes.